JP2023536068A5 - - Google Patents
Info
- Publication number
- JP2023536068A5 JP2023536068A5 JP2023503219A JP2023503219A JP2023536068A5 JP 2023536068 A5 JP2023536068 A5 JP 2023536068A5 JP 2023503219 A JP2023503219 A JP 2023503219A JP 2023503219 A JP2023503219 A JP 2023503219A JP 2023536068 A5 JP2023536068 A5 JP 2023536068A5
- Authority
- JP
- Japan
- Prior art keywords
- crystal
- crystal according
- peaks
- cancer
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063053921P | 2020-07-20 | 2020-07-20 | |
| US63/053,921 | 2020-07-20 | ||
| PCT/US2021/033618 WO2022019998A1 (en) | 2020-07-20 | 2021-05-21 | Crystal forms of crenolanib and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023536068A JP2023536068A (ja) | 2023-08-23 |
| JP2023536068A5 true JP2023536068A5 (https=) | 2024-01-24 |
Family
ID=79460325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023503219A Pending JP2023536068A (ja) | 2020-07-20 | 2021-05-21 | クレノラニブの結晶形態およびそれを用いる方法 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4181923A4 (https=) |
| JP (1) | JP2023536068A (https=) |
| CN (1) | CN113956245A (https=) |
| CA (1) | CA3186319A1 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PA8580301A1 (es) * | 2002-08-28 | 2005-05-24 | Pfizer Prod Inc | Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos |
| EP1641780B1 (en) * | 2003-06-24 | 2008-11-12 | Pfizer Products Incorporated | Processes for the preparation of 1- [(benzoimidazole-1yl) quinolin-8-yl] piperidin-4-ylamine derivatives |
| KR101738063B1 (ko) * | 2012-09-21 | 2017-05-19 | 아로그 파마슈티칼스, 인코퍼레이티드 | 구조적으로 활성인 인산화된 ｆｌｔ３ 키나제의 억제 방법 |
| TWI599356B (zh) * | 2012-09-26 | 2017-09-21 | 安羅格製藥有限責任公司 | 抑制突變型ｃ－ｋｉｔ的方法 |
| BR112015016282A2 (en) * | 2013-01-07 | 2017-07-11 | Arog Pharmaceuticals, Inc. | crenolanib for treatment of mutated flt3 proliferative disorders |
| CN105294719B (zh) * | 2015-11-18 | 2017-12-22 | 乳源瑶族自治县大众药品贸易有限公司 | 一种氨基喹唑啉类衍生物的二对甲苯磺酸盐及其晶型 |
| EA201991078A1 (ru) * | 2016-11-02 | 2019-11-29 | Креноланиб для лечения пролиферативных расстройств, связанных с мутацией flt3 | |
| CN110840893A (zh) * | 2018-12-13 | 2020-02-28 | 安罗格制药有限责任公司 | 含克莱拉尼的药物组合物及其用途 |
-
2021
- 2021-05-21 CA CA3186319A patent/CA3186319A1/en active Pending
- 2021-05-21 JP JP2023503219A patent/JP2023536068A/ja active Pending
- 2021-05-21 EP EP21846106.9A patent/EP4181923A4/en active Pending
- 2021-06-09 CN CN202110642513.2A patent/CN113956245A/zh active Pending